A phase I clinical trial with monoclonal antibody ch806 targeting   transitional state and mutant epidermal growth factor receptors (vol   104, pg 4071, 2007)

Scott Andrew M<sup>*</sup>; Lee Fook Thean; Tebbutt Niall; Herbertson Rebecca; Gill Sanjeev S; Liu Zhanqi; Skrinos Effie; Murone Carmel; Saunder Timothy H; Chappell Bridget; Papenfuss Anthony T; Poon Aurora M T; Hopkins Wendie; Smyth Fiona E; MacGregor Duncan; Cher Lawrence M; Jungbluth Achim A; Ritter Gerd; Brechbiel Martin W; Murphy Roger; Burgess Antony W; Hoffman Eric W; Johns Terrance G; Old Lloyd J

doi:10.1073/pnas.0708144104

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors (vol 104, pg 4071, 2007)

作者：Scott Andrew M^*; Lee Fook Thean; Tebbutt Niall; Herbertson Rebecca; Gill Sanjeev S; Liu Zhanqi; Skrinos Effie; Murone Carmel; Saunder Timothy H; Chappell Bridget; Papenfuss Anthony T; Poon Aurora M T; Hopkins Wendie; Smyth Fiona E; MacGregor Duncan; Cher Lawrence M; Jungbluth Achim A; Ritter Gerd; Brechbiel Martin W; Murphy Roger; Burgess Antony W; Hoffman Eric W; Johns Terrance G; Old Lloyd J

来源：Proceedings of the National Academy of Sciences of the United States of America, 2007, 104(40): 15965-15965.

DOI：10.1073/pnas.0708144104